{"slug":"retatrutide-cognition","verification":{"valid":true,"entries":2,"head":"e2bf418336b6eb676f21a38dd39cdef8e0564b887f71b626e255a39ac42f9ef8"},"energy":{"passes":2,"tokens_in":16229,"tokens_out":3380,"tokens_total":19609,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"e2bf418336b6eb676f21a38dd39cdef8e0564b887f71b626e255a39ac42f9ef8"},"provenance":[{"ts":"2026-06-30T01:02:28.867Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Retatrutide for Cognition\nSlug: retatrutide-cognition\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"retatrutide\",\"name\":\"Retatrutide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"retatrutide\",\"name\":\"Retatrutide\",\"section_title\":\"Why Retatrutide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.\",\"**What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\",\"**Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.\\n2. **What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\\n3. **Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"}],\"drug_chains\":[],","response":"{\n  \"slug\": \"retatrutide-cognition\",\n  \"title\": \"Retatrutide for Cognition: Evidence-Graded Review\",\n  \"body\": \"## What's breaking down\\n\\nCognitive performance can decline when metabolic dysfunction, chronic low-grade inflammation, and vascular strain outpace brain repair mechanisms. Excess body weight is one established contributor, linked to higher dementia risk through systemic inflammation and impaired glucose handling in neural tissue. These layers compound over time, shifting the balance toward degeneration rather than regeneration.\\n\\n## Why Retatrutide might help you\\n\\n1. **What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.\\n2. **What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\\n3. **Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\\n\\nIn the context of cognition, the same weight-loss pathway may indirectly ease metabolic strain on the brain if obesity is a contributing factor.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Retatrutide** → metabolic load / body weight\\n\\n## What the evidence actually shows\\n\\nNo human trials have tested retatrutide specifically for cognitive outcomes or dementia prevention (source s1). One 2026 preclinical study in streptozotocin-induced diabetic rats found that retatrutide preserved spatial learning and short-term memory versus untreated diabetic controls, with reduced TNF-α inflammation and partial maintenance of hippocampal structure; it did not improve cognition beyond healthy controls (source s2, preclinical). Observational data on the broader GLP-1 receptor agonist class show mixed associations with lower dementia in","tokens_in":16229,"tokens_out":3380,"cost":0,"prev":"genesis","hash":"297b657bda158d14994a275eec2b9ead6938f07066387407970aabae03251dd0"},{"ts":"2026-07-17T02:41:15.703Z","model":"owner","action":"voxel_divide","prompt":"","input":"retatrutide-cognition","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"297b657bda158d14994a275eec2b9ead6938f07066387407970aabae03251dd0","hash":"e2bf418336b6eb676f21a38dd39cdef8e0564b887f71b626e255a39ac42f9ef8"}]}